UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 399

Sortiert nach

Glucose toxicity: The leading actor in the pathogenesis and clinical history of type 2 diabetes – mechanisms and potentials for treatment

Nutrition, metabolism, and cardiovascular diseases, 2009-06, Vol.19 (5), p.365-377

2009

Volltextzugriff (PDF)

Management of diabetes in older adults

Nutrition, metabolism, and cardiovascular diseases, 2018-03, Vol.28 (3), p.206-218

2018

Volltextzugriff (PDF)

Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study

Journal of endocrinological investigation, 2024-06, Vol.47 (6), p.1395-1403

2024

Volltextzugriff (PDF)

Publish and perish

Nutrition, metabolism, and cardiovascular diseases, 2017-12, Vol.27 (12), p.1035-1036

Giaccari, Andrea

2017

Volltextzugriff (PDF)

Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans

Metabolism, clinical and experimental, 2021-01, Vol.114, p.154414-154414, Article 154414

2021

Volltextzugriff (PDF)

Vitamin D Deficiency: A New Risk Factor for Type 2 Diabetes?

Annals of nutrition and metabolism, 2012-01, Vol.61 (4), p.337-348

2012

Volltextzugriff (PDF)

Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives

Nutrition, metabolism, and cardiovascular diseases, 2012-02, Vol.22 (2), p.81-87

2012

Volltextzugriff (PDF)

Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population

Nutrition, metabolism, and cardiovascular diseases, 2019-05, Vol.29 (5), p.496-503

2019

Volltextzugriff (PDF)

Welcome aboard

Nutrition, metabolism, and cardiovascular diseases, 2015-01, Vol.25 (1), p.1-2

Giaccari, Andrea

2015

Volltextzugriff (PDF)

Corrigendum to “Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population” [Nutr Metabol Cardiovasc Dis 29 (5) (May 2019) 496–503]

Nutrition, metabolism, and cardiovascular diseases, 2019-08, Vol.29 (8), p.869-870

2019

Volltextzugriff (PDF)

A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus

Expert review of clinical pharmacology, 2017-07, Vol.10 (7), p.763-772

2017

Volltextzugriff (PDF)

Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results

Nutrition, metabolism, and cardiovascular diseases, 2012-12, Vol.22 (12), p.1007-1012

2012

Volltextzugriff (PDF)

CA-125: Méta-analyse des essais de phase 3a EDITION sur un an, concernant le contrôle glycémique et l'hypoglycémie des patients diabétiques de type 2 (DT2) sous insuline glargine 300 U/mL (Gla-300) vs insuline glargine 100 U/mL (Gla-100)

Diabetes & metabolism, 2016-03, Vol.42, p.A69-A69

2016

Volltextzugriff (PDF)

In anorexia nervosa, even a small increase in abdominal fat is responsible for the appearance of insulin resistance

Clinical endocrinology (Oxford), 2011-08, Vol.75 (2), p.202-206

2011

Volltextzugriff (PDF)

Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials

Nutrition, metabolism, and cardiovascular diseases, 2021-03, Vol.31 (3), p.699-704

2021

Volltextzugriff (PDF)

Role of physicians’ misperceived cardiovascular risk and therapeutic inertia in LDL-cholesterol targets achievement in diabetes

Atherosclerosis, 2022-08, Vol.355, p.221

2022

Volltextzugriff (PDF)

Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke

The New England journal of medicine, 2017-06, Vol.376 (25), p.2437-2447

2017

Volltextzugriff (PDF)

Glucose toxicity

Diabetes care, 1990-06, Vol.13 (6), p.610

1990

Volltextzugriff (PDF)

All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials

Nutrition, metabolism, and cardiovascular diseases, 2022-02, Vol.32 (2), p.511-514

2022

Volltextzugriff (PDF)

Effects of glucosamine infusion on insulin secretion and insulin action in humans

Diabetes (New York, N.Y.), 2000-06, Vol.49 (6), p.926-935

2000

Volltextzugriff (PDF)

Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study

The journal of clinical endocrinology and metabolism, 2013-05, Vol.98 (5), p.2100-2105

2013

Volltextzugriff (PDF)

Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study

Nutrition, metabolism, and cardiovascular diseases, 2011-09, Vol.21 (9), p.699-705

2011

Volltextzugriff (PDF)

Metabolic Syndrome in Transplant Patients: An Academic or a Health Burden?

Transplantation proceedings, 2011, Vol.43 (1), p.313-317

2011

Volltextzugriff (PDF)

P5.2 Diagnosis of early myelin involvement in diabetes as first sign of polyneuropathy: single fiber conduction velocity test

Clinical neurophysiology, 2011, Vol.122, p.S77-S78

2011

Volltextzugriff (PDF)

Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study

Atherosclerosis, 2018-10, Vol.277, p.413-418

2018

Volltextzugriff (PDF)

1 – 25 von 399

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(348)
Mit Volltextzugriff
(352)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Glucose toxicity: The leading actor in the pathogenesis and clinical history of type 2 diabetes – mechanisms and potentials for treatment

Management of diabetes in older adults

Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study

Publish and perish

Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans

Vitamin D Deficiency: A New Risk Factor for Type 2 Diabetes?

Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives

Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population

Welcome aboard

Corrigendum to “Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population” [Nutr Metabol Cardiovasc Dis 29 (5) (May 2019) 496–503]

A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus

Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results

CA-125: Méta-analyse des essais de phase 3a EDITION sur un an, concernant le contrôle glycémique et l'hypoglycémie des patients diabétiques de type 2 (DT2) sous insuline glargine 300 U/mL (Gla-300) vs insuline glargine 100 U/mL (Gla-100)

In anorexia nervosa, even a small increase in abdominal fat is responsible for the appearance of insulin resistance

Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials

Role of physicians’ misperceived cardiovascular risk and therapeutic inertia in LDL-cholesterol targets achievement in diabetes

Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke

Glucose toxicity

All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials

Effects of glucosamine infusion on insulin secretion and insulin action in humans

Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study

Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study

Metabolic Syndrome in Transplant Patients: An Academic or a Health Burden?

P5.2 Diagnosis of early myelin involvement in diabetes as first sign of polyneuropathy: single fiber conduction velocity test

Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study

Suchergebnisse filtern